Arsenic trioxide combined with dasatinib (Src and BCR-ABL inhibitor) synergistically inhibited the proliferation and induced apoptosis of Philadelphia chromosome-positive (Ph+) ALL cells (SUP-B15) and negative ALL cells (TOM-1). The gene discussed is BCR; the disease is acute lymphoblastic leukemia.